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Otorrhoea due to either external or middle-ear path-
ology is often difficult to treat. Different geographical 
areas may have unique patterns of infecting organisms 
and antimicrobial susceptibility. Worldwide, there has 
been a change in the profile of organisms causing 
otorrhoea and increases have been observed both in the incidence of 
methicillin-resistant Staphylococcus aureus (MRSA) and in resistance to 
antimicrobials.[1] In South Africa (SA), patients with otorrhoea are often 
initially treated at the primary healthcare level. Otorrhoea is seldom 
investigated by microscopy, culturing or sensitivity testing; treatment 
is usually empirical and has limited options. Although treatment is 
protocol driven, a PubMed search failed to reveal SA studies focusing 
purely on the bacteriology and antimicrobial sensitivities of chronic 
otorrhoea underpinning the management advice offered.
Aims
To investigate the microbiology profiles of patients presenting to a 
tertiary hospital in Cape Town with chronic otorrhoea and to ascertain 
the validity of the current treatment protocol for chronic otorrhoea 
outlined by the SA Department of Health (DoH). 
Methods
We conducted a prospective study at the tertiary-level Groote Schuur 
Hospital (GSH) in Cape Town over 4 years from 2005 to 2009. Patients 
with chronically discharging ears, who were referred to the Ear, Nose 
and Throat (ENT) Outpatients Unit by primary and secondary level 
services, were enrolled at their first visit to the hospital.
To best reflect the clinical situation at primary or secondary care 
level, we defined chronic otorrhoea as an ear discharge present 
for ≥2 weeks, either due to otitis media or otitis externa. We 
based the diagnosis of otitis media on the presence of a tympanic 
membrane (TM) perforation with the otorrhoea originating from 
the middle ear. We defined otitis externa as an intact TM and an 
inflamed, discharging lining of the external auditory canal. Our 
exclusion criteria included: patients with cholesteatoma, patients 
who had previous surgery, anatomical factors predisposing patients 
to recurrent ear infection, patients with foreign bodies, cerebrospinal 
fluid otorrhoea and patients who had received systemic or topical 
antibiotics in the 2 weeks prior to presenting to the hospital. 
To obtain a representative sample of the ear discharge, ear toilet 
was first performed with a diagnostic microscope before a pus swab 
was carefully taken with a single mini-tip culture swab under direct 
microscopic vision. The swab was generally too big to pass through 
a TM perforation, and thus the discharge was sampled just lateral to 
the TM.
Pus swabs were analysed by GSH’s microbiology laboratory, a 
SA National Accreditation System accredited laboratory, within the 
National Health Laboratory Service (NHLS). Swabs were inoculated 
onto blood agar, boiled blood agar and MacConkey agar and 
incubated for up to 48 hours. Isolates were identified using standard 
laboratory techniques and antimicrobial susceptibility testing was 
performed using either the Vitek 2 system (bioMérieux, France) or 
standard Kirby Bauer disc diffusion test. Results were interpreted 
using Clinical and Laboratory Standards Institute (CLSI) guidelines.[2]
Results
Seventy-nine patients met the inclusion criteria for the study with a 
mean age of 39 years (range 13 - 83 years). The female-to-male ratio 
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was 1.3:1 and the ratio of left to right ears 
was 1.2:1. Eight patients volunteered that 
they were HIV positive, 42 that they were 
negative and 35 did not know their HIV 
status. The duration of otorrhoea ranged 
from 4 to >100 weeks (mean 47 weeks). 
Otorrhoea had been present for >52 weeks 
in 34 (43%) patients.
Of the 79 patients enrolled in the study, 
50 had otitis media, 21 had otitis externa 
and in 8 patients this distinction was not 
documented. In 31 patients the treatment that 
they had received prior to referral had been 
documented and included oral antibiotics, 
i.e. amoxicillin (n=24), ciprofloxacin (n=2), 
flucloxacillin (n=1) and amoxicillin-clavu-
lanate (n=1). Five patients had received 
topical acetic acid drops, 2 of whom had also 
received amoxicillin.
Proteus mirabilis (36%; 18/50) was the 
most common isolate in otitis media while 
Pseudomonas aeruginosa (33%; 7/21) occurred 
most commonly in otitis externa (Table 1).
The patterns of susceptibility are listed 
in Table 2. MRSA, which was sensitive to 
erythromycin, was detected in only 1 patient 
(with otitis media) – a 35-year-old HIV-
positive patient with a 2-year history of 
otorrhoea.
Discussion
Our results describe the microbiology 
associated with chronic otorrhoea (both otitis 
externa and otitis media) in patients referred 
from primary and secondary healthcare 
facilities in the Western Cape. The most 
common organisms were P. mirabilis (29%), 
P. aeruginosa (20%) and S. aureus (15%). The 
microbiology associated with otitis media 
differed from otitis externa, with P. mirabilis 
(36%) and P.  aeruginosa (33%) being the 
most common isolates, respectively (Table 1). 
Our results roughly parallel the microbiology 
pattern reported by Loock[3] at another 
tertiary hospital in Cape Town in chronic 
otitis media patients, namely Proteus spp. 
(29%), P. aeruginosa (24%) and S. aureus 
(14%) as the most common.
A problem when comparing our results 
with those of some other studies is that they 
refer to ‘chronic suppurative otitis media’, 
defined as ‘inflammation of the middle ear and 
mastoid process, accompanied by a perforated 
tympanic membrane and discharge’.[1] In such 
studies, sampling would include otorrhoea 
due to cholesteatoma (treatment of which is 
surgical) and non-cholesteatomatous ears. 
Although most studies indicate that only non-
cholesteatoma cases were included, this is not 
true for all reports. Although some African 
studies reported P.  mirabilis to be the most 
common organism, other international studies 
report S. aureus and P. aeruginosa to be the 
most common organisms encountered with 
chronic suppurative otitis media.[1,4-7] A recent 
Nigerian study reported that Gram-negative 
bacteria (Klebsiella spp., Escherichia coli and 
P. aeruginosa) comprised 80% of isolates.[7] 
The microbiology with cholesteatoma is fairly 
similar, with a predominance of P. aeruginosa 
(31%) and S. aureus (19%), but there is also a 
significant anaerobic component.[8]
The incidence of MRSA in Cape Town is 
low compared with other studies. In our study, 
MRSA was isolated in only 1 patient (1.7%) 
with otitis media for 2 years; it is not known 
what treatment the patient had received at 
primary care facilities. This is similar to the 
1.9% incidence of MRSA reported by Loock[3] 
in patients with chronic active otitis media. 
These results differ from reports of changing 
bacteriological spectra and increases in the 
incidences of S. aureus and MRSA.[1] Hwang et 
al.[1] reported from Taiwan that, when compared 
with Juan (1986),[1] there had been an 8.5% 
increase in the incidence of MRSA in acute 
otitis externa; they also reported an increase in 
MRSA with granular myringitis, and that the 
biggest change in microbiology profile – a 15% 
increase in MRSA – had occurred with chronic 
otitis media.[1] Similar trends were observed in 
a large study from Korea, with the prevalence 
of MRSA increasing from 21.4% to 27.4%. [1] 
Hwang et al.[1] postulated that the change from 
P. aeruginosa to S. aureus, especially MRSA, 
could be attributed to improvements in public 
healthcare, reduced severity of ear disease 
and a more liberal use of antimicrobial drug 
therapy.
At primary care level, chronic otorrhoea 
is treated medically with ear toilet according 
Table 1. Culture results
Otitis media (N=50)
n (%)
Otitis externa (N=21)
n (%)
All cases (N=79)
n (%)
Proteus mirabilis 18 (36) 1 (5) 23 (29)
Staphylococcus aureus 7 (14) 5 (24) 12 (15)
Pseudomonas aeruginosa 7 (14) 7 (33) 16 (20)
Other bacteria* 4 (8) - 6 (8)
Fungal - 1 (5) 1 (1)
Mixed growth/only skin flora† 14 (28) 7 (33) 21 (26)
* E. coli, Enterobacter cloacae, Alcaligenes faecalis.† No distinct organism cultured.
Table 2. Antibiotic sensitivities of isolates from patients with otorrhoea for both otitis media and otitis externa 
P. mirabilis (N=23)
n (%)
P. aeruginosa (N=16)
n (%)
S. aureus (N=12)
n (%)
Other organisms (N=6)
n
All organisms
(%)
Ciprofloxacin 23 (100) 16 (100) 10 (83) 6 96
Gentamycin 23 (100) 13 (81) 4 (33) 6 81
Amikacin 23 (100) 16 (100)  - 5 77
Ampicillin 20 (87)  - 1 (8) 2 40
Amoxicillin/
clavulanate
23  -  -  - 41
Cefotaxime 23  -  -  - 41
Cefuroxime 22  -  -  - 39
Ceftazidime  - 16  - 6 39
Co-trimoxazole 14  -  - 4 32
Tobramycin  - 10  - 6 28
Oxacillin  -  - 11  - 19
Erythromycin  -  - 11  - 19
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to set protocols. Only when otorrhoea does 
not resolve are patients referred to a more 
specialised service. As otorrhoea generally 
is not cultured and an accurate distinction 
between otitis externa and media is usually 
not made at primary care level, commonly 
encountered pathogenic organisms should 
inform empiric treatment protocols. The 
current DoH guideline for treatment of 
chronic otitis media recommends amoxicillin 
or co-trimoxazole for patients allergic to 
penicillin (Table 3).[9] Many of the patients 
in our study had received amoxicillin in 
accordance with this guideline. Although 
the majority of the P. mirabilis isolates were 
susceptible to amoxicillin, only 40% of 
organisms overall were susceptible. 
The organisms isolated in our study were 
susceptible mainly to fluoroquinolones 
(96%) and aminoglycosides (81%) (Table 2). 
Topical fluoroquinolone eardrops, commonly 
ofloxacin or ciprofloxacin, are known to be 
as effective as aminoglycoside drops, and 
have the advantage of not being ototoxic. [10] 
Ofloxacin has been shown to be very 
effective in all studies except for a study 
done in Malawi[6] that reported that after 
an initial 73% response rate at 10 days, the 
response rate dropped to 42% at 21 weeks. 
However, most ears (in 91 candidates) in this 
study harboured faecal bacteria, and it was 
postulated that this finding was due not to 
bacterial resistance, but due to poor hygiene. [6] 
In keeping with previous studies, Loock[3] 
reported that topical quinolone eardrops were 
effective in the management of active chronic 
otitis media. Weber et al.[11] showed that no 
significant antibiotic resistance emerged from 
the use of topical antibiotics.
Our results suggest that should additional 
antibiotic therapy be considered in patients 
who have failed to respond to first-line 
therapy in a primary care setting, agents with 
better activity against Gram-negative bacilli 
should then be considered.
Another concern highlighted by our study 
was that 43% of patients had a discharging 
ear for >52 weeks. The reasons for this 
delayed referral to specialist centres require 
further research. We were unable to analyse 
the effect of HIV status on otorrhoea; further 
microbiological investigation at primary 
care level is required to determine whether it 
differs from HIV-negative patients.
Conclusions
Otorrhoea is generally treated at primary 
care level in SA and, hence, has to be proto-
col driven. Antimicrobials (topically or 
systemically) recommended for otorrhoea 
in the DoH guideline need to cover the 
majority of organisms encountered; be it 
due to otitis media, granular myringitis or 
otitis externa, as the primary healthcare 
worker is unlikely to distinguish between 
these causes of otorrhoea. The results of this 
study suggest that the microbial spectrum 
in the Western Cape, and possibly the rest 
of SA, differs from elsewhere in the world 
and that MRSA infection is uncommon. 
Amoxicillin appears to be a suboptimal 
choice for chronic non-responders due to 
its low sensitivity when compared with 
topical fluoroquinolone eardrops with ear 
mopping, which covers 95% of organisms 
cultured and is not ototoxic. Should the 
first-line treatment fail then an antibiotic 
group with Gram-negative cover should be 
considered.
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Table 3. Current SA DoH guideline for chronic otitis media[9] 
Non-drug treatment Avoid getting the inside of the ear wet
Dry mopping
Topical 1% acetic acid or diluted vinegar solution
Drug treatment Amoxicillin
Penicillin allergy: Co-trimoxazole
SA = South African; DoH = Department of Health.
